0
Please log in or register to do it.

Celltrion

Celltrion

(Seoul = Larose.VIP) Reporter Cho Hyun-young = Celltrion[068270]The company’s three treatments, including ‘Truxima’, a treatment for blood cancer, will be supplied to Peru.

According to Celltrion on the 15th, the company’s blood cancer treatment drug ‘Truxima’ (ingredient name: rituximab) succeeded in winning the drug supply bid from the Peruvian Ministry of Health (CENARES) and the Workers’ Compensation Corporation (EsSalud).

The Ministry of Health will be supplied with Truxima 500mg products twice, and the Corporation will be supplied with Truxima 100mg products for one year starting this month. As a result, Celltrion will occupy more than 50% of the corresponding drug market in Peru, including original drugs. .

In addition, in the bidding conducted by the Peruvian Workers’ Insurance Corporation, ‘Herzuma’ (ingredient name: Trastuzumab), an anti-cancer biosimilar used to treat breast cancer and stomach cancer, and ‘Uplyma’ (ingredient name: adalimumab), an autoimmune disease treatment, were successful bidders. done.

Accordingly, Celltrion secured 53% of the Peruvian trastuzumab market and 20% of the adalimumab market.

Celltrion also plans to launch subcutaneous injection-type autoimmune disease treatment ‘Remsima SC’ and ‘Begzelma’, which is used for colorectal cancer and non-small cell lung cancer, in Peru in the middle of this year and at the end of the year, respectively.

Kang Kyeong-du, head of Celltrion’s Central and South American region, said, “As we face events throughout Central and South America this year that can increase market influence, such as product launches and bidding participation, we will strengthen our marketing activities so that the results achieved in Peru can be expanded to neighboring countries.”

hyun0@yna.co.kr

Report to KakaoTalk okjebo 2024/02/15 09:30 Sent

Jeungpyeong-gun, last year’s birth growth rate was the 4th highest among basic local governments nationwide.
Will ‘Alliance Vacation’ begin? Hallym University Medical School 4th year student: “I will discontinue my studies for a year”

Reactions

0
0
0
0
0
0
Already reacted for this post.

Reactions

Your email address will not be published. Required fields are marked *